Skip to main content

Table 3 Distribution of disease-modifying antirheumatic drug in 100 rheumatoid arthritis patients

From: Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction

 

Disease-modifying antirheumatic drug

 

None

Methotrexate

Leflunomide

Sulfasalazopyrine

Gold

Chloroquine

Others

Number

22

42

10

10

6

4

6